On September 9, 2023, the '2023 Radiation Physics Symposium' was successfully concluded in Hefei, Anhui Province.
Many scholars and experts in the field of radiation physics were invited to this conference. The whole meeting emphasized the theme of 'seeking innovation, promoting cultivation, and strengthening the grassroots'. Focusing on the practice and research of radiation oncology physics, the training and education of radiation physicists, and the development of primary physicists, we focus on the development of new radiotherapy technology, standardized physicist training and education, clinical research transformation research, and multidisciplinary joint innovation. In the form of special lectures, paper reports, discussions and other forms, the latest achievements of academic research were exchanged, the knowledge and concepts of radiotherapy physics were updated, and the training of physicists was promoted.
During the exhibition, well-known figures, experts and scholars in the field of radiation physics from all over the country gathered together to discuss the latest achievements of radiation physics academic research. At the exhibition, PTW company, a German manufacturer of radiotherapy quality control equipment, specially set up a lunch satellite meeting, at which PTW professional engineers were invited to present the introduction of its core products to the guests and bring product demonstrations. The crowd was full and popular, attracting many experts and scholars to discuss, and the response was very warm. PTW products have been highly recognized by a number of experts attending the meeting.
As a distributor of PTW Company, our company is honored to participate in this meeting. Ruikang focuses on the field of tumor radiotherapy, and focuses on the research and development and production of tumor radiotherapy supporting products and consumables. Combined with the service tenet of 'reputation first, customer first', Ruikang provides integrated solutions for tumor radiotherapy departments and tumor patients who need to receive radiotherapy. The company maintains long-term in-depth cooperation with domestic authoritative tumor institutions and scientific research institutes, with the most professional tumor radiotherapy products and services, helping to upgrade the medical quality, making unremitting efforts to promote the rapid development of the medical industry and opening the journey of reforming the field of tumor radiotherapy and caring for tumor patients.
The success of this conference will undoubtedly further improve the technical level and quality of clinical application of radiation oncology physics.